Aldeyra Therapeutics Disclosed Clinical Development Plan For Resubmission Of New Drug Application For Reproxalap In Dry Eye Disease
Aldeyra Therapeutics公佈了重新提交治療乾眼病的瑞普沙拉普新藥申請的臨床開發計劃
Aldeyra Therapeutics Disclosed Clinical Development Plan For Resubmission Of New Drug Application For Reproxalap In Dry Eye Disease
Aldeyra Therapeutics公佈了重新提交治療乾眼病的瑞普沙拉普新藥申請的臨床開發計劃
使用瀏覽器的分享功能,分享給你的好友吧